CODE BIOTHERAPEUTICS
Company Overview
Social Media Profiles
About Code Biotherapeutics
Description
Code Biotherapeutics is an innovative gene therapy company focused on developing targeted, non-viral therapies aimed at treating serious genetic diseases. By harnessing next-generation technology, the company addresses unmet medical needs in the biotechnology and life sciences sectors, advancing the future of genetic medicine.
Specialties
Next-generation gene therapy
Targeted non-viral therapies
3DNA delivery platform
Duchenne Muscular Dystrophy research
Partnerships for genetic diseases
Products & Services
Gene Therapies
Duchenne Muscular Dystrophy Treatments
Non-Viral Delivery Systems
Genetic Medicine Research
Partnership Programs
Contact Information
No contact information available
Competitors & Similar Companies(10)
CRISPR Therapeutics
Massachusetts, • United States
Bluebird Bio
Massachusetts, • United States
Sangamo Therapeutics
British Columbia, • Canada
Sarepta Therapeutics
Editas Medicine
Massachusetts, • United States
Intellia Therapeutics
Massachusetts, • United States
Gene Therapy Solutions
Viroclinics Xplore
Overijssel, • Netherlands
AviadoBio
England, • United Kingdom • Biotechnology
News & Media
Search Terms:
code biotherapeuticscode bio
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Code Biotherapeutics
Where is Code Biotherapeutics located?
The headquarter of Code Biotherapeutics is located in Hatfield, Pennsylvania, United States
What is the official website of Code Biotherapeutics?
The official website of Code Biotherapeutics is https://www.codebiotx.com
What industry does Code Biotherapeutics belong to?
Code Biotherapeutics belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Code Biotherapeutics?
Code Biotherapeutics specializes in Next-generation gene therapy, Targeted non-viral therapies, 3DNA delivery platform, Duchenne Muscular Dystrophy research, Partnerships for genetic diseases.
What products and services is Code Biotherapeutics likely to offer?
Code Biotherapeutics offers Gene Therapies, Duchenne Muscular Dystrophy Treatments, Non-Viral Delivery Systems, Genetic Medicine Research, Partnership Programs.
Who are the competitors of Code Biotherapeutics?
Competitors of Code Biotherapeutics are CRISPR Therapeutics, Bluebird Bio, Sangamo Therapeutics, Sarepta Therapeutics, Rocket Pharmaceuticals, Editas Medicine, Intellia Therapeutics, Gene Therapy Solutions, Viroclinics Xplore, AviadoBio.
What does Code Biotherapeutics do?
Code Biotherapeutics is an innovative gene therapy company focused on developing targeted, non-viral therapies aimed at treating serious genetic diseases. By harnessing next-generation technology, the company addresses unmet medical needs in the biotechnology and life sciences sectors, advancing the future of genetic medicine.